For instance, miR-153 can significantly reduce expression of synuclein-alpha (SNCA) (Je and Kim, 2017), which has been confirmed to be relevant to the pathogenesis of PD (Lesage et al., 2020; Kung et al., 2022). Here, SNCA is linked to Parkinson disease.